Geode Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $242M | Buy |
|
|||||
|
2024
Q4 | $143M | Buy |
|
|||||
|
2024
Q3 | $125M | Buy |
|
|||||
|
2024
Q2 | $116M | Sell |
|
|||||
|
2024
Q1 | $143M | Buy |
|
|||||
|
2023
Q4 | $143M | Buy |
|
|||||
|
2023
Q3 | $99.6M | Buy |
|
|||||
|
2023
Q2 | $116M | Buy |
|
|||||
|
2023
Q1 | $94.7M | Buy |
|
|||||
|
2022
Q4 | $88.5M | Buy |
|
|||||
|
2022
Q3 | $75.3M | Buy |
|
|||||
|
2022
Q2 | $90.7M | Buy |
|
|||||
|
2022
Q1 | $90M | Buy |
|
|||||
|
2021
Q4 | $67.3M | Buy |
|
|||||
|
2021
Q3 | $47.4M | Buy |
|
|||||
|
2021
Q2 | $51.2M | Buy |
|
|||||
|
2021
Q1 | $40.5M | Buy |
|
|||||
|
2020
Q4 | $35.2M | Buy |
|
|||||
|
2020
Q3 | $25.7M | Buy |
|
|||||
|
2020
Q2 | $21.6M | Buy |
|
|||||
|
2020
Q1 | $12.4M | Buy |
|
|||||
|
2019
Q4 | $21.9M | Sell |
|
|||||
|
2019
Q3 | $4.87M | Buy |
|
|||||
|
2019
Q2 | $8.36M | Buy |
|
|||||
|
2019
Q1 | $7.46M | Buy |
|
|||||
|
2018
Q4 | $5.97M | Buy |
|
|||||
|
2018
Q3 | $10.8M | Buy |
|
|||||
|
2018
Q2 | $8.29M | Buy |
|
|||||
|
2018
Q1 | $8.78M | Buy |
|
|||||
|
2017
Q4 | $5.81M | Buy |
|
|||||
|
2017
Q3 | $5.32M | Buy |
|
|||||
|
2017
Q2 | $3.56M | Buy |
|
|||||
|
2017
Q1 | $4.4M | Buy |
|
|||||
|
2016
Q4 | $3.96M | Buy |
|
|||||
|
2016
Q3 | $3.76M | Buy |
|
|||||
|
2016
Q2 | $8.57M | Buy |
|
|||||
|
2016
Q1 | $5.7K | Buy |
|
|||||
|
2015
Q4 | $10.4M | Buy |
|
|||||
|
2015
Q3 | $6.74M | Buy |
|
|||||
|
2015
Q2 | $5.27M | Buy |
|
|||||
|
2015
Q1 | $3.74M | Buy |
|
|||||
|
2014
Q4 | $2.02M | Buy |
|
|||||
|
2014
Q3 | $1.53M | Buy |
|
|||||
|
2014
Q2 | $1.28M | Buy |
|
|||||
|
2014
Q1 | $1.01M | Buy |
|